Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder
Completed
Lotus Clinical Research, LLC
Phase 4
2023-10-12
This is an in-clinic, single arm, open-label study assessing tachyphylaxis, tolerance, and
withdrawal following repeated doses of Igalmi in adult males and females with agitation
associated with schizophrenia or bipolar disorder.
Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder
Completed
BioXcel Therapeutics Inc
Phase 4
2023-10-12
This is an in-clinic, single arm, open-label study assessing tachyphylaxis, tolerance, and
withdrawal following repeated doses of Igalmi in adult males and females with agitation
associated with schizophrenia or bipolar disorder.
Evaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bipolar Disorder
Recruiting
BioXcel Therapeutics Inc
Phase 4
2023-07-01
An open-label, randomized, active control inpatient trial to evaluate the efficacy and
tolerability of sublingual dexmedetomidine for the treatment of agitation in inpatients with
schizophrenia or bipolar disorder as measured by the Positive and Negative Syndrome Scale -
Excited Component (PANSS-EC) and Agitation-Calmness Evaluation Scale (ACES). Lorazepam will
serve as the active control.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
